Osaic Holdings
CMPX icon

Osaic Holdings’s Compass Therapeutics CMPX Stock Holding History

Osaic Holdings’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$77.6K Buy
14,678
+14,621
+25,651% +$84.4K ﹤0.01% 4864
2025
Q4 		$306 Buy
+57
New +$263 ﹤0.01% 7518
2023
Q1 		– Sell
-100
Closed -$1K – 7509
2022
Q4 		$1K Hold
100
– – ﹤0.01% 6849
2022
Q3 		$0 Hold
100
– – ﹤0.01% 7282
2022
Q2 		$0 Buy
+100
New +$217 ﹤0.01% 7368

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Osaic Holdings's CMPX Position: Q1 2026 in Review

Osaic Holdings increased its Compass Therapeutics (CMPX) stake by 25,651% in Q1 2026, buying an estimated $84.4K and bringing the position to 14,678 shares worth $77.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4864.

Osaic Holdings first reported a position in CMPX in Q2 2022 and has held it in 5 quarters since. 201 funds tracked by Wall St. Rank hold CMPX as of Q1 2026.

  • Osaic Holdings held 14,678 shares of Compass Therapeutics worth $77.6K as of Q1 2026.
  • Osaic Holdings bought 14,621 Compass Therapeutics shares in Q1 2026, an estimated $84.4K.
  • Compass Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #4864 holding.
  • Osaic Holdings first reported a position in Compass Therapeutics in Q2 2022 and has held it in 5 quarters since.
  • 201 funds tracked by Wall St. Rank held Compass Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.